Aurobindo Pharma Buyback 2024 vs KDDL Buyback 2024

Comparision between Aurobindo Pharma Buyback 2024 and KDDL Buyback 2024.

Buyback Details

Aurobindo Pharma Buyback 2024 is a Tender Offer buyback proposed to list at BSE, NSE while KDDL Buyback 2024 is a Tender Offer proposed to list at BSE, NSE.

	Aurobindo Pharma Limited	KDDL Ltd
Logo
Type of Buyback	Tender Offer	Tender Offer
Listing At	BSE, NSE	BSE, NSE
Face Value	₹1 per share	₹10 per share
Buyback Price	₹1460 per share	₹3700 per share
Issue Size	51,36,986 shares	2,37,837 shares
Issue Size (Amount)	₹750.00 Crores	₹88.00 Crores
Buyback Ratio
Registrar	Kfin Technologies Limited
Lead Managers	Axis Capital Limited
Necessity of the buyback	The Buy-Back is being undertaken, inter-alia, for the following reasons: The buy-back will help the company reward its shareholders and enhance the overall return to shareholders. The buy-back is expected to improve earnings per share and other key ratios such as return on net worth and return on assets over a period of time; The buy-back is being implemented through the tender offer route as prescribed under the buyback regulations and would involve the allocation of the number of equity shares as per their entitlement or 15% of the number of equity shares to be bought back, whichever is higher, reserved for small shareholders.

Buyback Timetable

Aurobindo Pharma Buyback 2024 and KDDL Buyback 2024 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aurobindo Pharma Buyback 2024 Buyback record date is Jul 30, 2024. KDDL Buyback 2024 Buyback record date is .

	Aurobindo Pharma Limited	KDDL Ltd
Record Date	Jul 30, 2024
Offer Open Date
Offer Closure Date
Last date for receipt of tender forms
Finalisation of buyback
Last Date for settlment of bids
Last Date for extinguishment of shares

Financial Details and Other Relevent Information

Comparison of Aurobindo Pharma Buyback 2024 and KDDL Buyback 2024 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

Aurobindo Pharma Limited

KDDL Ltd

Financial

Aurobindo Pharma Limited Financial Information (Restated)

Aurobindo Pharma Limited's revenue increased by 26.52% and profit after tax (PAT) rose by 59.25% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023
Assets	2,515.40	2,505.88
Revenue	1,126.17	890.09
Profit After Tax	195.41	122.71
Amount in ₹ Crore

KDDL Ltd Financial Information (Restated Consolidated)

KDDL Ltd's revenue increased by 36.94% and profit after tax (PAT) rose by 106.94% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	1,160.53	739.46	617.54
Revenue	1,138.76	831.58	567.24
Profit After Tax	76.98	37.20	6.97
Reserves and Surplus	240.61	203.75	161.29
Total Borrowing	127.55	154.98	155.82
Amount in ₹ Crore

Stock price at BSE

Stock price at NSE

Compare with others

Aurobindo Pharma Limited	KDDL Ltd
KDDL Buyback 2024	Aurobindo Pharma Buyback 2024
Godawari Power and Ispat Buyback 2024	Godawari Power and Ispat Buyback 2024
Cheviot Company Buyback 2024	Cheviot Company Buyback 2024
eClerx Services Buyback 2024	eClerx Services Buyback 2024
Bajaj Consumer Care Buyback 2024	Bajaj Consumer Care Buyback 2024
	Ajanta Pharma Buyback 2024

Comments

Add a public comment...